SEC Filing Details

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Mar 25, 2022
Document Date
Apr 26, 2022
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.

©2019- Theravance Biopharma.  All rights reserved.  Terms of Use.  Privacy Policy.  Social Media Guidelines.

THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE®, are registered trademarks, and TARGETING WHAT MATTERS MOST™ is a trademark of the Theravance Biopharma group of companies (in the U.S. and certain other countries). YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris Company. Trademarks, trade names or service marks of other companies appearing on this website are the property of their respective owners.